The effect of reinforced endotracheal tube on post-operative hoarseness undergoing thyroidectomy

Status

Recruiting

Phases

Phase 2

Study type

Interventional

Source

CRIS

Registry ID

KCT0003331

Enrollment

140

Registered

2018-11-09

Start date

2017-07-27

Completion date

Unknown

Last updated

2019-03-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

None listed

Interventions

Medical Device : Oral/Nasal Endotracheal Tube, Reinforced(Covidien) 7.0mmID, 8.0mmID vs. TaperGuard oral tracheal tube(Covidien) 7.0mmID, 8.0mmID

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologists Physical Status (ASA PS) 1-3 20 to 70 years Patients undergoing general anesthesia undergoing thyroidectomy Patients without preoperative vocal cord anomalies Patients with a tumor size less than 2 cm

Exclusion criteria

Exclusion criteria: Patients with anticipated difficult tracheal intubation (Mallampati class = 3) Patients with respiratory disease Patients with sore throat, neck pain, and dysphagia Obesity (BMI> 30 kg / m 2) Previous Oral and Pharyngeal Surgery Patient Patients with Rarecurrent Laryngeal Nerve

Design outcomes

Primary

Measure	Time frame
incidence of hoarseness	—

Secondary

Measure	Time frame
incidence and severity of sore throat, swallowing difficulty and coughing	—

Countries

Korea, Republic of

Contacts

Public ContactJia Song

Chonnam National University Hospital

mirejia@naver.com+82-62-220-6895

Outcome results